TotalMarketCap

Idexx Laboratories

IDXXNasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$52.899 B

$671.42 -3.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Idexx Laboratories (IDXX) has a market capitalization of $52.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.30B

#743 by revenue

Earnings

$1.06B

#375 by earnings

Shares outstanding

78,786,265

Latest filing cover page

P/E ratio

49.9

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #1Idexx LaboratoriesIDXX$52.9B
  2. #2LantheusLNTH$6.58B
  3. #3Oruka TherapeuticsORKA$6.36B
  4. #4NeogenNEOG$2.54B
  5. #5Celldex TherapeuticsCLDX$2.22B

What if Idexx Laboratories were worth as much as…

Open the what-if tool →

Gold $28.2T

$358,398.43

Per share 534× higher

Bitcoin $1.53T

$19,392.32

Per share 28.9× higher

Apple $5.02T

$63,663.16

Per share 94.8× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Idexx Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.